In the RA group, the baseline DAS-28 CRP score was 5.08 ± 1.3 for those without baseline polypharmacy and 4.74 ± 1.25 for those with baseline polypharmacy, and these values were significantly different from each other (p = 0.046). This evidence concerns the gene CRP and rheumatoid arthritis.